Published in Leukemia on July 01, 2002
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26
The DNA sequence and analysis of human chromosome 13. Nature (2004) 1.33
The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia. Clin Cancer Res (2011) 0.99
Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region. Tumour Biol (2009) 0.80
Patterns of Chromosomal Aberrations in Solid Tumors. Recent Results Cancer Res (2015) 0.77
Bcl-2 level as a biomarker for 13q14 deletion in CLL. Cytometry B Clin Cytom (2013) 0.76
Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia (2009) 6.29
A study of proximal and distal intestinal structure and absorptive function in idiopathic steatorrhoea. Q J Med (1967) 4.68
Method of assay of red cell folate activity and the value of the assay as a test for folate deficiency. J Clin Pathol (1966) 4.44
Impaired Fas response and autoimmunity in Pten+/- mice. Science (1999) 4.25
Tissue antibodies in dermatitis herpetiformis and adult coeliac disease. Lancet (1971) 3.50
The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci U S A (1991) 3.12
Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet (1967) 3.11
Circulating immune complexes in dermatitis herpetiformis. Lancet (1973) 2.78
Anti-reticulin antibodies in childhood coeliac disease. Lancet (1971) 2.54
Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia (2007) 2.40
Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassemia major. Blood (1992) 2.29
Folic acid fortification and cancer risk. Lancet (2007) 2.17
Antireticulin antibody: incidence and diagnostic significance. Gut (1973) 2.15
Lymphocytic infiltration of epithelium in diagnosis of gluten-sensitive enteropathy. Br Med J (1972) 2.11
Effect of gluten-free diet on dermatological, intestinal, and haematological manifestations of dermatitis herpetiformis. Lancet (1968) 2.09
Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet (1973) 2.01
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet (1982) 2.01
Parenteral acyclovir therapy for herpesvirus infections in man. Lancet (1979) 1.99
The human thymic microenvironment: an immunohistologic study. J Immunol (1980) 1.94
Combined therapy with deferiprone and desferrioxamine. Br J Haematol (1998) 1.91
Agranulocytosis and thrombocytopenia in patient with Blackfan-Diamond anaemia during oral chelator trial. Lancet (1989) 1.91
Folate deficiency and neurological disease. Lancet (1965) 1.85
Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol (1996) 1.82
Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload. Lancet (1976) 1.81
Waldenström's macroglobulinemia: clinical features, complications, and management. J Clin Oncol (2000) 1.72
Hypoparathyroidism and hypocalcaemia during treatment for acute leukaemia. Br Med J (Clin Res Ed) (1982) 1.72
Improvement in iron status and liver function in patients with transfusional iron overload with long-term subcutaneous desferrioxamine. Lancet (1979) 1.70
The rhombotin gene belongs to a class of transcriptional regulators with a potential novel protein dimerisation motif. Oncogene (1990) 1.68
hOCT1 transcript levels and single nucleotide polymorphisms as predictive factors for response to imatinib in chronic myeloid leukemia. Leukemia (2010) 1.67
ACAPs are arf6 GTPase-activating proteins that function in the cell periphery. J Cell Biol (2000) 1.66
Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936. Leukemia (2006) 1.62
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
Gluten-free diet and reintroduction of gluten in dermatitis herpetiformis. Arch Dermatol (1969) 1.60
Bone-marrow aspiration and trephine biopsy (1). Br Med J (1980) 1.58
Mechanism of folate deficiency in patients receiving phenytoin. Lancet (1968) 1.58
Influenza virus vaccine in B-cell chronic lymphocytic leukaemia patients. Acta Haematol (1994) 1.55
Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia. Lancet (1982) 1.55
The hematologic complications following partial gastrectomy. A study of 292 patients. Am J Med (1967) 1.55
The small intestine in dermatitis herpetiformis. J Clin Pathol (1974) 1.54
Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol (2000) 1.54
Immunoglobulins in the skin in dermatitis herpetiformis and coeliac disease. Lancet (1972) 1.53
Unusual megaloblastic anaemia wiht multinucleate erythroblasts: two cases with septicaemia and acute renal failure. J Clin Pathol (1975) 1.53
Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies. J Natl Cancer Inst (1980) 1.50
Increased numbers of cells with suppressor T cell phenotype in the peripheral blood of patients with infectious mononucleosis. Clin Exp Immunol (1981) 1.45
Multiple immune complexes and hypocomplementaemia in dermatitis herpetiformis and coeliac disease. Lancet (1976) 1.45
Iron chelation therapy: the need for orally active drugs. J Lab Clin Med (1998) 1.42
Human B cell development. I. Phenotypic differences of B lymphocytes in the bone marrow and peripheral lymphoid tissue. J Immunol (1985) 1.41
Serum immunoreactive trypsin in beta-thalassaemia major. J Clin Pathol (1981) 1.41
Stomatococcus mucilaginosus: an emerging pathogen in neutropenic patients. Clin Infect Dis (1992) 1.39
Thalidomide and dexamethasone combination for refractory multiple myeloma. Ann Oncol (2001) 1.39
Lack of clonal BCRA2 gene deletion on chromosome 13 in chronic lymphocytic leukaemia. Br J Haematol (1997) 1.38
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial. Br Med J (Clin Res Ed) (1983) 1.37
Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet (1988) 1.35
Absorption of crystalline folic acid in man. Lancet (1968) 1.35
Folate deficiency in Crohn's disease: incidence, pathogenesis, and treatment. Br Med J (1968) 1.34
Multiparameter studies in lymphoid leukemias. Am J Clin Pathol (1979) 1.34
Folate deficiency in premature infants. Arch Dis Child (1970) 1.33
Iron and folate metabolism in tuberculosis. Br Med J (1966) 1.33
Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet (1997) 1.32
Orally active alpha-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbits. Br J Haematol (1986) 1.31
Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells. Br J Haematol (1976) 1.30
High incidence of cardiomyopathy in beta-thalassaemia patients receiving regular transfusion and iron chelation: reversal by intensified chelation. Acta Haematol (1990) 1.30
Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia. Lancet (1980) 1.29
Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet (1986) 1.29
Streptococcus mitis and ARDS in neutropenic patients. Lancet (1991) 1.28
Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one. Br Med J (Clin Res Ed) (1987) 1.28
Mechanisms of resistance of human acute leukaemia cells to cytosine arabinoside. Br J Haematol (1974) 1.28
Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice. Mol Cell Biol (2004) 1.26
Splenic atrophy in dermatitis herpetiformis. Br Med J (1972) 1.25
Studies of folate uptake by phytohaemagglutinin-stimulated lymphocytes. Br J Haematol (1970) 1.25
Comparison of three methods for measuring vitamin B 12 in serum: radioisotopic, euglena gracilis and Lactobacillus leichmannii. Br J Haematol (1972) 1.23
Indices of granulocyte activity in inflammatory bowel disease. Gut (1974) 1.21
Alternate-pathway complement fixation by IgA in the skin in dermatitis herpetiformis. Lancet (1973) 1.20
Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med (1993) 1.20
Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years' experience. Clin Infect Dis (1993) 1.19
1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload. Lancet (1987) 1.19
Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine. J Clin Pathol (1987) 1.17
High prevalence of low bone mass in thalassaemia major. Br J Haematol (1998) 1.15
Development of pluripotent hematopoietic progenitor cells in the human fetus. Blood (1983) 1.15
High incidence of Notch-1 mutations in adult patients with T-cell acute lymphoblastic leukemia. Leukemia (2006) 1.14
Effect of ascorbic acid deficiency on serum ferritin concentration in patients with beta-thalassaemia major and iron overload. J Clin Pathol (1982) 1.14
Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis. Br J Haematol (1999) 1.13
DNA rearrangements of immunoglobulin genes correlate with phenotypic markers in B-cell malignancies. Mol Biol Med (1984) 1.13
B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J Investig Med (2001) 1.13
Absorption of vitamin B 12 by the guinea-pig. I. Subcellular localization of vitamin B 12 in the ileal enterocyte during absorption. Br J Haematol (1970) 1.13
Heavy metal intoxication from homeopathic and herbal remedies. Postgrad Med J (1994) 1.12
The effect of deoxyuridine, vitamin B12, folate and alcohol on the uptake of thymidine and on the deoxynucleoside triphosphate concentrations in normal and megaloblastic cells. Br J Haematol (1978) 1.12
Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet (1981) 1.11
The effect of external deoxyribonucleosides on deoxyribonucleoside triphosphate concentrations in human lymphocytes. Biochem Pharmacol (1975) 1.10
The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients. Haematologica (2001) 1.10
Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine. Lancet (1977) 1.08
Heterogeneity of T-cell beta-chain gene rearrangements in human leukaemias and lymphomas. EMBO J (1985) 1.08
Pharmacokinetics of the oral iron chelator deferiprone (L1) in patients with iron overload. Br J Haematol (1995) 1.07
The subcellular localization of pteroyl polyglutamate hydrolase and folate in guinea pig intestinal mucosa. Biochim Biophys Acta (1969) 1.07
The excretion of foriminoglutamic acid and urocanic acid after partial gastrectomy. Lancet (1966) 1.07
Chaetomium pneumonia in patient with acute myeloid leukaemia. J Clin Pathol (1996) 1.07
Serum lysozyme and vitamin B 12 binding capacity in myeloproliferative disorders. Br J Haematol (1971) 1.06
Anaemia in adult coeliac disease. Clin Gastroenterol (1974) 1.06